Together, these findings demonstrate that cfRNA- and ctcRNA-based liquid biopsy using <i>CRX</i> and <i>RBP3</i> enables sensitive and dynamic detection of disseminated retinoblastoma, particularly in bone marrow, and supports its potential utility for MRD monitoring. The gene discussed is RBP3; the disease is retinoblastoma.